Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Watch
Expert ConversationsNews & AnalysisShows & Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
Conferences
Conference CoverageConference ListingPost Conference Perspectives
More
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Watch
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement

Ben Leach

Advertisement

Articles by Ben Leach

In Historic Vote, FDA Backs Perjeta for Pre-surgical Breast Cancer Treatment

ByBen Leach
October 22nd 2013

Ofatumumab Receives Breakthrough Therapy Designation for Earlier Use in CLL

ByBen Leach
October 22nd 2013

Optimal Paclitaxel Schedule Identified for Early-Stage Breast Cancer

ByBen Leach
August 23rd 2013

I-SPY Trials Seek Effective New Drug Combinations Using Adaptive Trial Design

ByBen Leach
June 18th 2013

Exploring New Ways to Broaden the Reach of Molecular Tumor Testing

ByBen Leach
December 6th 2012

Study Supports Feasibility of Routine Molecular Screening of NSCLC in Community Setting

ByBen Leach
September 21st 2012
Advertisement

Latest Updated Articles

  • Study Supports Feasibility of Routine Molecular Screening of NSCLC in Community Setting
    Study Supports Feasibility of Routine Molecular Screening of NSCLC in Community Setting

    September 21st 2012

  • Exploring New Ways to Broaden the Reach of Molecular Tumor Testing
    Exploring New Ways to Broaden the Reach of Molecular Tumor Testing

    December 6th 2012

  • I-SPY Trials Seek Effective New Drug Combinations Using Adaptive Trial Design
    I-SPY Trials Seek Effective New Drug Combinations Using Adaptive Trial Design

    June 18th 2013

  • Optimal Paclitaxel Schedule Identified for Early-Stage Breast Cancer
    Optimal Paclitaxel Schedule Identified for Early-Stage Breast Cancer

    August 23rd 2013

  • In Historic Vote, FDA Backs Perjeta for Pre-surgical Breast Cancer Treatment
    In Historic Vote, FDA Backs Perjeta for Pre-surgical Breast Cancer Treatment

    October 22nd 2013

  • Ofatumumab Receives Breakthrough Therapy Designation for Earlier Use in CLL
    Ofatumumab Receives Breakthrough Therapy Designation for Earlier Use in CLL

    October 22nd 2013



Advertisement
Advertisement

Trending on AJMC

1

FDA Panel Backs 6 Peptides for Compounding

2

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

3

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

4

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access

5

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2026 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text